• Blog
  • Immunofluorescence Assays Market Report

    Immunofluorescence Assays Market Report

    Immunofluorescence Assays Market Report
    Report code - SR1504 Delivery - 2 Weeks
    Immunofluorescence Assays Market Growth, Trends, Dynamics & Market Insights: 2021-2026 See more...

    Market Insights

    The Immunofluorescence Assays Market is estimated to grow from USD 2.5 billion in 2020 to USD 3.6 billion by 2026 at a healthy CAGR of 6.3% during the forecast period.

    Wish to get a free sample? Register Here

    What is immunofluorescence?

    Immunofluorescence is a light microscopy method with a fluorescence microscope, which is primarily used on microbiological samples. This technique employs the sensitivity of antibodies to their antigen to guide fluorescent dyes to specific biomolecule targets inside a cell, enabling visualization of the target molecule's distribution within the sample.

    Key Players

    Key players operating in the immunofluorescence assays market are-

    • Thermo Fisher Scientific Inc. (US)
    • Inova Diagnostics, Inc. (US)
    • Bio-Rad Laboratories, Inc. (US)
    • Abcam (UK)
    • PerkinElmer Inc. (US)
    • Merck Millipore (US)
    • Cell Signaling Technology (US)
    • MEDIPAN GMBH (Germany)
    • Sino Biological (China)
    • Danaher Corporation (US).

    Market Dynamics

    The growing prevalence of chronic and infectious diseases such as rheumatoid arthritis, cancer, Alzheimer’s, HIV AIDS, and Parkinson’s are likely to augment the immunofluorescence assay market in the coming years. Moreover, the rising R&D spending & healthcare expenditure further boost the market growth. However, the high cost of assay kits and screening instruments is anticipated to hinder the industry's growth. Nevertheless, the developing economies of Brazil, China, and India are expected to offer potential growth opportunities in the following years.

    COVID-19 Impact

    The COVID-19 outbreak positively influenced the growth of the immunofluorescence assay market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. The COVID-19 pandemic has increased the demand for immunofluorescence assays as people are consuming immunity-booster products to increase immunity to prevent the transmission of coronavirus around the globe. Hence, several manufacturers are trying to develop new products to keep up with the high demand, thus boosting the market growth.

    Segment Analysis

    Type Trends

    The market has been classified into indirect immunofluorescence and direct immunofluorescence. The indirect immunofluorescence segment accounted for a substantial market share in 2020. The benefits of indirect immunofluorescence are high sensitivity and easy to change signal color based on changing the second antibody which can get commercially. The labeled second antibodies are easily obtained. Secondary antibodies are relatively cheaper than primary antibodies, which further boosts the segment growth.

    Regional Analysis

    The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to favorable government initiatives, established healthcare infrastructure, and the high prevalence of infectious diseases and cancer in the region, which is likely to boost regional growth. Moreover, beneficial government initiatives and a rise in the number of research partnerships further proliferate regional growth.

    To get the full scope of the report, Register Here

    Target Audience

    Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What deliverables will you get in this report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Immunofluorescence Assays Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The immunofluorescence assays market is expected to witness an impressive growth of 6.3% CAGR in the coming years.

    Thermo Fisher Scientific Inc. (US), Inova Diagnostics, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abcam (UK), PerkinElmer Inc. (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), and Danaher Corporation (US) are among the key players in the immunofluorescence assays market.

    The immunofluorescence assays market size is expected to reach USD 3.6 billion in the foreseeable future.

    Indirect immunofluorescence segment accounted for a substantial share in the immunofluorescence assays market in 2020.

    North America is expected to remain dominant in the immunofluorescence assays market in the next five years.

    The growing prevalence of chronic and infectious diseases such as rheumatoid arthritis, cancer, Alzheimers, HIV AIDS, and Parkinsons are likely to augment the immunofluorescence assay market in the coming years. Moreover, the rising R&D spending & healthcare expenditure further boost the market growth.